Protein-Based Purification Matrices for Biologic Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biologic purification methods, such as affinity chromatography, are expensive, time-consuming, and difficult to scale, requiring skilled labor and equipment, and often fail to efficiently remove host cell proteins, nucleic acids, and viruses from biologic preparations.
Innovation Solution
The use of protein-based purification matrices comprising a capture domain and a polypeptide with phase behavior, which binds to biologics or contaminants, allowing for size-based separation through environmental factors like temperature or salt concentration changes, using techniques like tangential flow filtration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If affinity chromatography is used for biologic purification, then high purity (>90%) is achieved, but the process becomes expensive, time-consuming, and difficult to scale
Solution Approach 1:
The invention changes the physical-chemical parameters of the purification system by using phase separation based on temperature and salt concentration rather than affinity-based chromatography. The purification matrix undergoes liquid-liquid phase separation to selectively partition biologics into one phase while leaving contaminants in another, enabling rapid purification without the slow flow rates and scaling limitations of affinity chromatography
Solution Approach 2:
The invention exploits phase transitions of the purification matrix between soluble and insoluble states. By controlling temperature and salt concentration, the matrix transitions to an insoluble phase that selectively binds and separates biologics from contaminants. This phase transition mechanism enables fast separation and is easily scalable, overcoming the productivity limitations of affinity chromatography while maintaining high purity
2Reliability
If affinity chromatography is used for biologic purification, then high selectivity for target biologic is achieved, but expensive equipment and skilled labor are required
Solution Approach 1:
The invention replaces expensive, complex affinity chromatography equipment with simple, disposable purification matrices. These matrices can be prepared in advance and used in straightforward phase separation procedures that require minimal equipment and no specialized technical expertise, dramatically reducing both equipment costs and skilled labor requirements while maintaining reliable selectivity
Solution Approach 2:
The invention replaces the complex mechanical and operational systems of affinity chromatography (pumps, columns, gradient systems) with a simple phase separation process. The separation is driven by inherent physical-chemical properties of the purification matrix rather than complex mechanical systems, eliminating the need for expensive equipment and reducing operational complexity
3Productivity
If column diameter is increased for scaling affinity chromatography, then production capacity is improved, but conditions become non-linear and purification becomes difficult to scale
Solution Approach 1:
The invention creates a universal purification approach where the same phase separation mechanism works across all scales. The purification matrix maintains consistent performance whether processing small or large volumes, and the process can be easily adapted to different production capacities without changing fundamental conditions. This universality enables straightforward scaling from laboratory to industrial production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables rapid, cost-effective purification of biologics with high yield and purity (>70%) by forming complexes that can be easily separated from contaminants, reducing the need for expensive equipment and skilled labor, and improving scalability.
Implementation Method 1
a polypeptide with phase behavior
Implementation Method 2
the complex is separated from at least one contaminant on the basis of size
Implementation Method 3
the biologic is separated from the purification matrix by a second environmental factor
Data Source
AI summary
Provided herein are protein-based purification matrices and methods of use thereof to purify biologics and/or to remove contaminants from a composition. Methods of bringing two or more biologics in close proximity are also provided. The disclosed compositions and methods allow for faster, more efficient purification of a biologic compared to traditional affinity chromatography.